LARGEMOUTH LATEST: NOVEMBER 2021 EDITION
Each month we recap some of our client communications results in action, proud moments and helpful resources for PR and marketing pros. Want to keep up with us once a month? Subscribe to our agency newsletter.
COVER STORY CONTENT
S.T. Wooten, an award-winning, family-owned construction company, is making progress on a major I-95 road widening project that will help ease traffic for travelers in North Carolina. Our team secured a unique contributed article opportunity with trade publication Roads & Bridges to highlight the project and benefits it will bring for drivers coming up and down the East Coast. Helping manage story development through interviews with S.T. Wooten and the North Carolina Department of Transportation (NCDOT), the in-depth piece is helping build industry awareness for the expansive job.
FLYING HIGH IN MEDIA PLACEMENTS
flyExclusive made a triumphant return to the in-person tradeshow circuit in October with a major presence at the 2021 NBAA Business Aviation Convention & Exhibition. As one of the fastest-growing brands in private aviation with a focus on premium experiences, the company used the venue as a prime opportunity to unveil major enhancements to its Jet Club membership program as well as new capabilities for refurbishing both aircraft exteriors and interiors. Largemouth used the opportunity to strategically forge and grow strong relationships with key industry media, such as Aviation International News, Aviation Week and Corporate Jet Investor, creating a runway for future success as flyExclusive continues its explosive growth trajectory.
ROCKING AND "RHO"ING WITH COVERAGE
Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, is the Statistical and Clinical Coordinating Center for the COVID-19 Vaccine in Autoimmune Disease Non-Responders study. This clinical trial is assessing the antibody response to an extra dose of an authorized or approved COVID-19 vaccine in people with autoimmune diseases who did not respond to an original COVID-19 vaccine regimen. Our team secured an article with the Triangle Business Journal, a key local business publication, as well as clinical research trade publications. Additionally, the press release was picked up by several national media outlets including Bloomberg.